Phase 1 evaluation of UniFluVec: safety and reactogenicity of an intranasal universal influenza vector vaccine at two dose levels

Marina Stukova, Tatiana Zubkova, Zhanna Buzitskaya, Anna-Polina Shurygina, Mariana Erofeeva, Vladimir Nebolsin

Open source

DOI
10.18527/20251216879
Published
2025
Container
Microbiology Independent Research Journal (MIR Journal)
Publisher
Doctrine
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18527/20251216879,
  title = {Phase 1 evaluation of UniFluVec: safety and reactogenicity of an intranasal universal influenza vector vaccine at two dose levels},
  author = {Marina Stukova and Tatiana Zubkova and Zhanna Buzitskaya and Anna-Polina Shurygina and Mariana Erofeeva and Vladimir Nebolsin},
  year = {2025},
  journal = {Microbiology Independent Research Journal (MIR Journal)},
  doi = {10.18527/20251216879},
  url = {https://doi.org/10.18527/20251216879}
}

RIS

TY  - JOUR
TI  - Phase 1 evaluation of UniFluVec: safety and reactogenicity of an intranasal universal influenza vector vaccine at two dose levels
AU  - Marina Stukova
AU  - Tatiana Zubkova
AU  - Zhanna Buzitskaya
AU  - Anna-Polina Shurygina
AU  - Mariana Erofeeva
AU  - Vladimir Nebolsin
PY  - 2025
JO  - Microbiology Independent Research Journal (MIR Journal)
DO  - 10.18527/20251216879
UR  - https://doi.org/10.18527/20251216879
ER  - 

APA

Stukova, M., Zubkova, T., Buzitskaya, Z., Shurygina, A., Erofeeva, M., & Nebolsin, V. (2025). Phase 1 evaluation of UniFluVec: safety and reactogenicity of an intranasal universal influenza vector vaccine at two dose levels. Microbiology Independent Research Journal (MIR Journal). https://doi.org/10.18527/20251216879

Source records